Reaction
Embolism Arterial reporting signals
As of the last recalculation, Embolism Arterial appears in 1,187 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is DROSPIRENONE AND ETHINYL ESTRADIOL (PRR 121.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Drospirenone And Ethinyl Estradiol | 243 | 121.0 | 121.6 |
| Romiplostim | 33 | 39.5 | 39.6 |
| Bleomycin Sulfate | 14 | 24.0 | 24.1 |
| Heparin Sodium | 16 | 20.7 | 20.7 |
| Etonogestrel And Ethinyl Estradiol | 23 | 18.5 | 18.5 |
| Norepinephrine Bitartrate | 13 | 16.0 | 16.0 |
| Norepinephrine | 9 | 14.9 | 14.9 |
| Dextrose | 11 | 14.8 | 14.8 |
| Dextrose Monohydrate | 11 | 14.6 | 14.6 |
| Bevacizumab | 84 | 12.7 | 12.7 |
| Cisplatin | 50 | 11.7 | 11.7 |
| Pemetrexed | 13 | 10.7 | 10.7 |
| Melphalan Hydrochloride | 15 | 10.6 | 10.6 |
| Alteplase | 9 | 10.6 | 10.6 |
| Melphalan | 13 | 10.1 | 10.1 |
| Dabigatran Etexilate | 43 | 10.0 | 10.0 |
| Atezolizumab | 21 | 9.6 | 9.6 |
| Dabigatran Etexilate Mesylate | 37 | 9.2 | 9.2 |
| Panitumumab | 8 | 9.0 | 9.0 |
| Gemcitabine Hydrochloride | 26 | 8.8 | 8.8 |
| Oxaliplatin | 36 | 8.7 | 8.7 |
| Gemcitabine | 19 | 8.6 | 8.6 |
| Pemetrexed Disodium | 18 | 8.4 | 8.4 |
| Irinotecan Hydrochloride | 6 | 8.2 | 8.2 |
| Fluorouracil Cream, 0.5% | 33 | 7.8 | 7.8 |
| Fluorouracil | 33 | 7.7 | 7.7 |
| Cetuximab | 12 | 6.8 | 6.8 |
| Paclitaxel (Aibumin-Bound) | 31 | 6.8 | 6.8 |
| Abiraterone | 5 | 6.5 | 6.5 |
| Encorafenib | 3 | 5.3 | 5.3 |
| Ranibizumab | 6 | 4.0 | 4.0 |
| Aflibercept | 7 | 4.0 | 4.0 |
| Osimertinib | 7 | 3.8 | 3.8 |